The Prague Post - Who should get paid for nature's sequenced genes?

EUR -
AED 4.223946
AFN 80.510557
ALL 97.475637
AMD 441.980718
ANG 2.058339
AOA 1053.539263
ARS 1337.023547
AUD 1.769193
AWG 2.070275
AZN 1.957965
BAM 1.943746
BBD 2.321404
BDT 140.608054
BGN 1.955609
BHD 0.433694
BIF 3382.598845
BMD 1.150153
BND 1.472767
BOB 7.973554
BRL 6.317905
BSD 1.149671
BTN 99.103435
BWP 15.370683
BYN 3.762567
BYR 22542.99128
BZD 2.309379
CAD 1.571241
CDF 3308.989332
CHF 0.939327
CLF 0.028339
CLP 1087.492391
CNY 8.263852
CNH 8.268223
COP 4714.475574
CRC 579.009418
CUC 1.150153
CUP 30.479044
CVE 109.695833
CZK 24.821099
DJF 204.405049
DKK 7.458027
DOP 68.261176
DZD 149.432603
EGP 57.695794
ERN 17.252289
ETB 155.045825
FJD 2.584106
FKP 0.845842
GBP 0.854914
GEL 3.12891
GGP 0.845842
GHS 11.857814
GIP 0.845842
GMD 82.249919
GNF 9955.721011
GTQ 8.830241
GYD 240.448916
HKD 9.028549
HNL 30.076594
HRK 7.533155
HTG 150.466917
HUF 403.979802
IDR 18775.091309
ILS 4.027018
IMP 0.845842
INR 99.247363
IQD 1506.699927
IRR 48450.179156
ISK 143.608181
JEP 0.845842
JMD 182.985263
JOD 0.815427
JPY 166.791625
KES 148.657242
KGS 100.581106
KHR 4623.613675
KMF 493.415223
KPW 1035.143263
KRW 1577.917796
KWD 0.352269
KYD 0.958158
KZT 596.500949
LAK 24814.542832
LBP 103027.107435
LKR 345.775758
LRD 229.627677
LSL 20.725326
LTL 3.396101
LVL 0.695716
LYD 6.23955
MAD 10.49511
MDL 19.637225
MGA 5089.425218
MKD 61.515245
MMK 2414.1161
MNT 4120.384358
MOP 9.295975
MRU 45.684601
MUR 52.55024
MVR 17.718132
MWK 1996.665142
MXN 21.83199
MYR 4.884123
MZN 73.552204
NAD 20.725961
NGN 1775.262756
NIO 42.268841
NOK 11.41293
NPR 158.565695
NZD 1.906688
OMR 0.44223
PAB 1.149671
PEN 4.154923
PGK 4.740066
PHP 65.496622
PKR 325.809472
PLN 4.275037
PYG 9184.047428
QAR 4.187134
RON 5.031459
RSD 117.214365
RUB 90.284688
RWF 1638.967478
SAR 4.315241
SBD 9.608794
SCR 16.793419
SDG 690.657152
SEK 10.96326
SGD 1.477273
SHP 0.903839
SLE 25.849656
SLL 24118.129503
SOS 657.313641
SRD 44.683033
STD 23805.837009
SVC 10.059618
SYP 14954.165597
SZL 20.725504
THB 37.489798
TJS 11.387881
TMT 4.025534
TND 3.384323
TOP 2.69377
TRY 45.470703
TTD 7.805596
TWD 33.962284
TZS 2996.147591
UAH 47.770976
UGX 4133.367953
USD 1.150153
UYU 47.237479
UZS 14618.44012
VES 117.349266
VND 30004.606379
VUV 137.919735
WST 3.164966
XAF 651.914316
XAG 0.030851
XAU 0.00034
XCD 3.108345
XDR 0.813457
XOF 652.71576
XPF 119.331742
YER 279.140307
ZAR 20.670934
ZMK 10352.754768
ZMW 27.989431
ZWL 370.348673
  • CMSC

    0.0900

    22.314

    +0.4%

  • CMSD

    0.0250

    22.285

    +0.11%

  • RBGPF

    0.0000

    69.04

    0%

  • SCS

    0.0400

    10.74

    +0.37%

  • RELX

    0.0300

    53

    +0.06%

  • RIO

    -0.1400

    59.33

    -0.24%

  • GSK

    0.1300

    41.45

    +0.31%

  • NGG

    0.2700

    71.48

    +0.38%

  • BP

    0.1750

    30.4

    +0.58%

  • BTI

    0.7150

    48.215

    +1.48%

  • BCC

    0.7900

    91.02

    +0.87%

  • JRI

    0.0200

    13.13

    +0.15%

  • VOD

    0.0100

    9.85

    +0.1%

  • BCE

    -0.0600

    22.445

    -0.27%

  • RYCEF

    0.1000

    12

    +0.83%

  • AZN

    -0.1200

    73.71

    -0.16%

Who should get paid for nature's sequenced genes?
Who should get paid for nature's sequenced genes? / Photo: Menahem KAHANA - AFP/File

Who should get paid for nature's sequenced genes?

Much of the vanilla that flavors our ice cream today is artificial, derived from the genetic signature of a plant that hundreds of years ago was known only to an Indigenous Mexican tribe.

Text size:

The plant's sequenced genomic information, available on public databases, was used as the basis for a synthetic flavoring that today competes with vanilla grown in several countries, mainly by small-scale farmers.

Few, if any, benefits of the lucrative scientific advance have trickled down to the communities that gave us vanilla in the first place.

"Wild genetic resources and pharmaceuticals ... are a multi-multi-billion dollar businesses. They clearly are profitable... that's not in dispute," Charles Barber of the World Resources Institute think tank told AFP.

"A great deal of really valuable information has fed into the system from research and utilization of wild genetic resources. And there is no mechanism currently to compensate the people where this information is coming from" in the form of digitally sequenced data, he added.

Much of the information comes from poor countries.

Fair sharing of the gains derived from digitally-stored genetic sequencing data has been a headache for negotiators at the COP16 biodiversity summit into its second week in Cali, Colombia.

At the last conference, in Montreal in 2022, 196 country parties to the UN's Convention on Biological Diversity (CBD) agreed to create a benefit-sharing mechanism for the use of digital sequence information (DSI).

Two years later, they still need to resolve such basic questions as who pays, how much, into which fund, and to whom does the money go?

- 'Cheap and very fast' -

The issue is a complex one.

There is little debate that genetic data-sharing on mostly free-access platforms is crucial for human advancement through medicine and vaccine development, for example.

But how to quantify the value of the sequenced information itself? And should the first people to discover a plant's particular usefulness be compensated?

"Sequencing technology has become so advanced that you can go with a... handheld device a little bit bigger than a cell phone and you can literally sequence a genome in an hour or two and upload it as you sequence it," Pierre du Plessis, a DSI expert and former negotiator for African countries at the CBD told AFP.

These gene sequences are then uploaded to databases which artificial intelligence can mine for potential leads for product development.

DSI is worth an estimated hundreds of billions of dollars a year. And there is a lot of it out there.

"Once the sequence is put into a public database, generally, no benefit-sharing obligations apply," Nithin Ramakrishnan, a researcher with the Third World Network, an advocacy NGO for developing countries, told AFP in Cali.

"Like when the sandalwood sequence information is available in the database whether India wants to share its sandalwood... with a cosmetic company or not, doesn't matter.

- Mandatory -

A point of contention in Cali is a demand from developing countries that payment for DSI use be mandatory, perhaps through a one-percent levy on profits from drugs, cosmetics or other products.

They also want guarantees of non-monetary benefits such as access to vaccines produced from genetic information sequenced from viruses and other pathogens.

"We want real understanding, sector-specific understanding of what non-monetary benefits will be shared and we want the system to be obligatory -- the users should have some form of obligation to share benefits," said Ramakrishnan.

Another sticking point is access for Indigenous people and local communities to DSI funds.

Developing countries want the information on genetic databases to be traceable and "answerable to governments" of the countries where it comes from, said Ramakrishnan.

But rich nations and many researchers oppose such a model which they fear will be too onerous, potentially putting the brakes on scientific pursuits that could benefit all humankind.

With such divergent points of view, observers are doubtful the Cali COP will emerge with any firm decisions on the outstanding questions by closing time on Friday.

The World Wildlife Fund has said "many more rounds of negotiations appear necessary" on DSI.

Added Barber: "I think it's not going to all get solved here."

T.Kolar--TPP